Genentech Disappointed With FDA Panel Vote For Revoking Avastin Approval
Roche's cancer drug Avastin, which costs less than Lucentis, also targets VEGF and doctors sometimes use it off- label to treat patients with age-related macular degeneration. Avastin costs $50 per shot, while Lucentis costs about $2000 for each Roche's cancer drug Avastin, which costs less than Lucentis, also targets VEGF and doctors sometimes use it [...]